. It is a condition that reportedly affects more than one in seven women and, at its most dangerous, can lead to self-harm or danger to the infant. Brexanolone arrived in 2019 with encouraging results but has to be administered intravenously and slowly by infusion over 60 hours in hospital. After new trials the US Food and Drug Administration has now approved zuranolone, a more logistically manageable pill form of the drug to take at home. It is limited to this specific use and for two weeks only, producing a statistically significant){kind=link}
For new mothers, so far only in the United States, there is a new drug for severe postpartum depression, the grim, irrational low mood after the birth of a baby (most commonly the first). It is a condition that reportedly affects more than one in seven women and, at its most dangerous, can lead to self-harm or danger to the infant.
Brexanolone arrived in 2019 with encouraging results but has to be administered intravenously and slowly by infusion over 60 hours in hospital. After new trials the US Food and Drug Administration has now approved zuranolone, a more logistically manageable pill form of the drug to take at home. It is limited to this specific use and for two weeks only, producing a statistically significant
© Times Media Limited 2023.
Registered in England No. 894646. Registered office: 1 London Bridge Street, SE1 9GF.